MedTrace Logo

Study to Evaluate the Efficacy of Alefacept to Treat Palmar Plantar Pustulosis

NCT00301002 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2006-11-23

No results posted yet for this study

Summary

The purpose of this study is to determine if Alefacept is effective in the treatment of palmar plantar pustulosis.

Conditions

  • Psoriasis
  • Palmoplantaris Pustulosis
  • Pustular Psoriasis of Palms and Soles
  • Pustulosis Palmaris et Plantaris
  • Pustulosis of Palms and Soles

Interventions

DRUG

Alefacept

Sponsors & Collaborators

  • Biogen

    collaborator INDUSTRY

  • The Guenther Dermatology Research Centre

    lead OTHER

Principal Investigators

  • Lyn C Guenther, MD, FRCPC · The Guenther Dermatology Research Centre

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Completion
2006-10-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00301002 on ClinicalTrials.gov